Real-World Clinical Outcomes and Prognostic Factors for Patients with Advanced Angiosarcoma who Received Systemic Treatment.

Park, Changhee; Kim, Miso; Kwak, Yoonjin; Moon, Kyung Chul; Kim, Se Hyun; Keam, Bhumsuk; Kim, Yu Jung; Kim, Tae Min; Kim, Dong-Wan

Park, Changhee; Kim, Miso; Kwak, Yoonjin; Moon, Kyung Chul; Kim, Se Hyun; Keam, Bhumsuk; Kim, Yu Jung; Kim, Tae Min; Kim, Dong-Wan.

Affiliation

Park C; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
Kim M; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
Kwak Y; Cancer Research Institute, Seoul National University, Seoul, Korea.
Moon KC; Department of Pathology, Seoul National University Hospital, Seoul, Korea.
Kim SH; Department of Pathology, Seoul National University Hospital, Seoul, Korea.
Keam B; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
Kim YJ; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
Kim TM; Cancer Research Institute, Seoul National University, Seoul, Korea.
Kim DW; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.

Cancer Res Treat ; 53(4): 1195-1203, 2021 Oct.

Article de En | MEDLINE | ID: mdl-33540493

Sujet(s)
Mots clés

Angiosarcoma; Paclitaxel; Pazopanib; Prognosis

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs cutanées / Protocoles de polychimiothérapie antinéoplasique / Hémangiosarcome / Tumeurs du foie Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: Cancer Res Treat Année: 2021 Type de document: Article Pays de publication:

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google